Cerenome (PSTV) Amortizatization of Intangibles (2015 - 2026)
Plus Therapeutics (PSTV) posted quarterly Amortizatization of Intangibles of $21000.0 for Q1 2026, up 310.0% quarter-over-quarter from -$10000.0 in Q4 2025.
Cerenome (PSTV) Amortizatization of Intangibles (2015 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has reported Amortizatization of Intangibles for 5 consecutive years, with $21000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Amortizatization of Intangibles changed N/A year-over-year to $21000.0; the TTM figure through Mar 2026 stood at $49000.0 (changed N/A YoY), while the FY2025 annual figure was $9000.0, down 91.89% from the prior year.
- Amortizatization of Intangibles climbed to $21000.0 in Q1 2026 per PSTV's latest filing, from -$10000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $47000.0 in Q3 2024 and bottomed at -$10000.0 in Q4 2025.
- Historically, Amortizatization of Intangibles has averaged $17000.0 across 3 years, with a median of $21000.0 in 2026.
- On a YoY basis, Amortizatization of Intangibles climbed as much as 106.38% in 2025 and fell as far as 124.39% in 2025.
- Plus Therapeutics' Amortizatization of Intangibles stood at $41000.0 in 2024, then sank by 124.39% to -$10000.0 in 2025, then soared by 310.0% to $21000.0 in 2026.
- Business Quant data shows PSTV's Amortizatization of Intangibles at $21000.0 in Q1 2026, -$10000.0 in Q4 2025, and -$3000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Cerenome | 28.07 Mn | 19.48 Mn | - | 6,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21,000.00 |
| Mar 31, 2026 | 21,000.00 |
| Dec 31, 2025 | -10,000.00 |
| Dec 31, 2025 | -10,000.00 |
| Sep 30, 2025 | -3,000.00 |
| Sep 30, 2025 | -3,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Sep 30, 2024 | 47,000.00 |
| Sep 30, 2024 | 47,000.00 |
| Jun 30, 2024 | 24,000.00 |
| Jun 30, 2024 | 24,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Jun 30, 2016 | 7,000.00 |
| Jun 30, 2016 | 7,000.00 |
| Mar 31, 2016 | 17,000.00 |
| Mar 31, 2016 | 17,000.00 |
| Dec 31, 2015 | 25,000.00 |
| Dec 31, 2015 | 25,000.00 |